Wolfgang Söhngen
Director/Board Member chez Metys Pharmaceuticals AG
Profil
Wolfgang Söhngen was the founder of PAION AG, which was founded in 2000, where he held the title of Chief Executive Officer from 2000 to 2019.
He is currently a Director at Metys Pharmaceuticals AG.
Dr. Söhngen's former positions include Co-Managing Director at Paion Deutschland GmbH, Non-Executive Director at PAION, Inc., and Head-Corporate Development & Strategic planning at Grünenthal GmbH from 1987 to 1997.
Dr. Söhngen received his undergraduate and doctorate degrees from RWTH Aachen University in 1985.
Postes actifs de Wolfgang Söhngen
Sociétés | Poste | Début |
---|---|---|
Metys Pharmaceuticals AG
Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Part of Novaremed AG, Metys Pharmaceuticals AG is a pharmaceutical company based in Basel, Switzerland. The Swiss company specializes in developing dimiracetam for the prevention of chemotherapy-induced neuropathic pain. The private company was founded by Michael Scherz, who has been the CEO since incorporation. Metys Pharmaceuticals was acquired by Novaremed AG on September 07, 2021. | Director/Board Member | - |
Anciens postes connus de Wolfgang Söhngen
Sociétés | Poste | Fin |
---|---|---|
PAION, Inc.
PAION, Inc. Pharmaceuticals: MajorHealth Technology Part of PAION AG, PAION, Inc. is a pharmaceutical manufacturing company. The private company is based in Mahwah, NJ. | Director/Board Member | 01/11/2019 |
PAION AG | Chief Executive Officer | 16/10/2019 |
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Corporate Officer/Principal | 01/12/1997 |
Paion Deutschland GmbH
Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Chief Executive Officer | - |
Formation de Wolfgang Söhngen
RWTH Aachen University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
PAION AG | Health Technology |
Entreprise privées | 4 |
---|---|
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Health Technology |
Paion Deutschland GmbH
Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Health Technology |
PAION, Inc.
PAION, Inc. Pharmaceuticals: MajorHealth Technology Part of PAION AG, PAION, Inc. is a pharmaceutical manufacturing company. The private company is based in Mahwah, NJ. | Health Technology |
Metys Pharmaceuticals AG
Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Part of Novaremed AG, Metys Pharmaceuticals AG is a pharmaceutical company based in Basel, Switzerland. The Swiss company specializes in developing dimiracetam for the prevention of chemotherapy-induced neuropathic pain. The private company was founded by Michael Scherz, who has been the CEO since incorporation. Metys Pharmaceuticals was acquired by Novaremed AG on September 07, 2021. | Health Technology |